Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 439,834,592
  • Shares Outstanding, K 2,614,484
  • Annual Sales, $ 93,775 M
  • Annual Income, $ 20,878 M
  • 60-Month Beta 0.56
  • Price/Sales 4.65
  • Price/Cash Flow 13.24
  • Price/Book 5.92
Trade JNJ with:

Options Overview Details

View History
  • Implied Volatility 15.24% ( -0.58%)
  • Historical Volatility 12.24%
  • IV Percentile 3%
  • IV Rank 8.87%
  • IV High 25.03% on 10/10/22
  • IV Low 14.28% on 12/02/22
  • Put/Call Vol Ratio 1.20
  • Today's Volume 31,342
  • Volume Avg (30-Day) 40,817
  • Put/Call OI Ratio 0.89
  • Today's Open Interest 394,276
  • Open Int (30-Day) 443,173

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate 2.51
  • Number of Estimates 6
  • High Estimate 2.56
  • Low Estimate 2.46
  • Prior Year 2.67
  • Growth Rate Est. (year over year) -5.99%

Price Performance

See More
Period Period Low Period High Performance
1-Month
166.01 +1.34%
on 01/24/23
180.93 -7.02%
on 01/06/23
-9.20 (-5.19%)
since 12/27/22
3-Month
166.01 +1.34%
on 01/24/23
181.04 -7.08%
on 12/14/22
-4.08 (-2.37%)
since 10/27/22
52-Week
155.72 +8.03%
on 02/24/22
186.69 -9.89%
on 04/25/22
-2.36 (-1.38%)
since 01/27/22

Most Recent Stories

More News
2 Blue Chips Under Pressure

Plus, Motley Fool personal finance expert Robert Brokamp answers your questions.

MMM : 115.25 (+1.50%)
JNJ : 168.23 (-0.39%)
BLK : 759.18 (+0.04%)
IVZ : 18.30 (-0.92%)
VXUS : 56.52 (-0.23%)
BND : 74.09 (-0.11%)
3 Beaten-Down Blue Chip Stocks to Buy Right Now

These solid stocks are down but definitely not out.

CVS : 87.78 (+0.14%)
JNJ : 168.23 (-0.39%)
UNH : 486.05 (-1.31%)
Save Yourself: Use Dividends for Stability

How do you keep yourself from committing the cardinal sin of panic-selling? We talk to a portfolio manager about where to find stability and income, which should help you keep your cool.

DIVZ : 29.25 (-0.25%)
CME : 175.68 (-0.62%)
JNJ : 168.23 (-0.39%)
ABBV : 146.28 (-0.76%)
VZ : 40.64 (+0.92%)
3 Low-Risk Dividend Stocks to Buy in 2023

These stocks should allow you to sleep peacefully no matter what happens with the stock market this year.

DEA : 15.94 (+1.21%)
JNJ : 168.23 (-0.39%)
PEP : 169.62 (-0.35%)
2 of the Best Dividend Stocks to Own in 2023

You can count on them for passive income and growth over time.

JNJ : 168.23 (-0.39%)
ABBV : 146.28 (-0.76%)
3 Retirement Stocks Under $200 to Buy Now

Despite cooling inflation, the Fed’s indication of continuing its hawkish stance and recession concerns could keep the stock market volatile for a while. Against this backdrop, fundamentally sound dividend...

ADM : 83.63 (-1.50%)
AYI : 185.12 (+1.65%)
JNJ : 168.23 (-0.39%)
Pharma Stock Roundup: JNJ Q4 Results Mixed, MRK Keytruda Prostate Cancer Study Ends

J&J (JNJ) reports mixed fourth-quarter results. Merck (MRK) discontinues an advanced prostate cancer study on blockbuster drug Keytruda for futility.

AZN : 65.53 (-0.70%)
NVS : 89.49 (-0.39%)
JNJ : 168.23 (-0.39%)
MRK : 105.38 (-1.39%)
LLY : 342.10 (-1.70%)
Should iShares Russell 1000 Value ETF (IWD) Be on Your Investing Radar?

Style Box ETF report for IWD

IWD : 158.81 (-0.08%)
JNJ : 168.23 (-0.39%)
XOM : 115.61 (-1.83%)
BRK.B : 309.17 (-0.57%)
VTV : 143.55 (-0.29%)
VYM : 110.26 (-0.39%)
3 Safe Stocks to Buy in an Unpredictable Market

The Fed’s intention to continue raising interest rates, disappointing economic data, and a weak earnings season could keep the stock market highly volatile. Hence, investing in quality stocks Microsoft...

JNJ : 168.23 (-0.39%)
MSFT : 248.16 (+0.06%)
NVS : 89.49 (-0.39%)
ETFs in Focus on JNJ's Mixed Q4 Earnings Results

The world's biggest healthcare products' maker continued with its long streak of earnings beat and missed revenue estimates.

JNJ : 168.23 (-0.39%)
XLV : 132.86 (-0.68%)
IYH : 278.79 (-0.63%)
VHT : 245.26 (-0.61%)
IHE : 185.70 (-0.46%)
PPH : 78.01 (-0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among...

See More

Key Turning Points

3rd Resistance Point 169.90
2nd Resistance Point 169.38
1st Resistance Point 168.81
Last Price 168.23
1st Support Level 167.71
2nd Support Level 167.19
3rd Support Level 166.62

See More

52-Week High 186.69
Fibonacci 61.8% 174.86
Fibonacci 50% 171.21
Last Price 168.23
Fibonacci 38.2% 167.55
52-Week Low 155.72

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar